Market Overview

Benzinga's Top Pre-Market Gainers

Related ACRX
Exclusive: AcelRx Pharma Execs Discuss Stock Performance, Catalysts And Financial Position
AcelRx: Replacing Morphine With Department Of Defense Funding
AcelRx Pharmaceuticals (ACRX) Presents at Family Office & Biotech Investment Symposium (Seeking Alpha)
Related TLAB
Temple to Distribute Tellabs Optical LAN in EMEA Markets
Top 4 Small-Cap Stocks In The Communication Equipment Industry With The Highest Revenue Estimates

AcelRx Pharmaceuticals (NASDAQ: ACRX) moved up 5.74% to $3.50 in the pre-market session. AcelRx Pharmaceuticals priced underwritten public offering of 12,500,000 shares of its common stock at a price of $3.31 per share.

Tellabs (NASDAQ: TLAB) soared 3.56% to $3.49 in the pre-market trading. Tellabs shares have dropped 18.99% over the past 52 weeks, while the S&P 500 index has gained 12.65% in the same period.

Smith & Wesson Holding (NASDAQ: SWHC) added 2.86% to $11.16 in the pre-market session. Smith & Wesson swung to a FQ2 profit and lifted its full-year forecast.

Caesars Entertainment (NASDAQ: CZR) surged 1.92% to $7.45 in the pre-market session. Caesars Entertainment's trailing-twelve-month revenue is $8.94 billion.

Posted-In: Top Pre-Market GainersNews Pre-Market Outlook Markets Movers


Related Articles (CZR + ACRX)

View Comments and Join the Discussion!